Ecstasy: Neurotoxicity and How It Can Be Reduced

Tuesday, September 2, 2008

5-HydroxytryptophanImage via Wikipedia

Molly Flannagan

Ecstasy (MDMA) has become a drug of choice among 18-25 year olds (2), and its effects on behavior and neurotoxicity merit the attention of this class. Ecstasy use has become fairly widespread on college campuses and in rave and nightclub settings. This paper will look at the mechanism through which MDMA acts, its neurotoxicity, and how users can reduce risk involved with ecstasy use.

How does ecstasy work?

Ecstasy alters behavior by increasing serotonin levels in the brain. It accomplishes this by altering the neurotransmitter serotonin's reuptake process. (6) In the normal serotonin system, a serotonin neuron will receive a signal from a neighboring nerve cell to release vesicles of serotonin into the synaptic cleft. The post-synaptic cell (which has the appropriate receptors for serotonin) then picks up the molecule. When the serotonin binds to the receptor, it causes an electric signal to change the membrane permeability which causes changes in the body. When a vesicle of serotonin is released, most of the molecules are pulled back into the pre-synaptic cell. This process of drawing serotonin back into the original neuron for it to be reused is called reuptake. When MDMA is present in the system, however, it interferes with the natural process by preventing the serotonin from entering at the reuptake site. This causes an excess of serotonin in the system, which creates the feelings of euphoria associated with MDMA. (1)

Just how neurotoxic is ecstasy?

Users of MDMA are quick to praise the psychological effects of the drug, but the effects on their physical health can be detrimental. Studies show that heavy, prolonged use of MDMA can significantly reduce the number of serotonin transporters which are necessary to bring the neurotransmitter back to the neuron from which it was released. Studies supported by the National Institute on Drug Abuse (NIDA) showed that MDMA damages neurons that release serotonin, and that heavy MDMA users have lingering memory problems for at least two weeks after stopping the drug. In the first study, researchers used positron emission tomography (PET) to compare the brains of MDMA users who had abstained from all psychoactive drugs for three weeks and people who had never used MDMA. They found that the amount of MDMA used was directly linked to the number of serotonin transporters remaining. They also found that the degree of memory impairment is based on the amount of MDMA used. (3)

How can the neurotoxic effects of ecstasy be reduced?

Pre- and Post-loading can be used to lessen the harmful effects of MDMA. Pre-loading is taking supplements before rolling to help counteract the neurotoxic effects of ecstasy. A common pre- load consists of 200mg of 5-Hydroxytryptophan (5-HTP), up to 100mg of Vitamin B-6, up to 1000mg of Vitamin C, and 100mg of Magnesium. (3) Adding more serotonin to the system can counteract the mechanism through which MDMA damages nerve cells. 5-HTP is the direct precursor to serotonin, and can therefore combat the neurotoxicity of MDMA. Vitamin B-6 helps to convert 5-HTP into serotonin, thereby boosting its effect. Because MDMA is thought to be neurotoxic due to oxidized free radicals, the consumption of the anti-oxidant Vitamin C can also reduce the harmful effects of MDMA. Magnesium is used as a muscle relaxer to minimize involuntary jaw-clenching associated with ecstasy use. A post-load consists of the same supplements except that magnesium is unnecessary. (4) It is also beneficial to drink water during and after the use of ecstasy.

How does it all fit together?

Ecstasy has been proven to be neurotoxic when heavy doses are used frequently. However, it also appears that a moderate use of the drug, combined with harm-minimizing supplements can help to counter the negative effects associated with it. Ecstasy has become one of the most popular drugs among college-age students, and its popularity shows no sign of decreasing. As a result, it is critical for users to be informed of the risks involved and how they can reduce these risks.

WWW Sources

1) Ecstasy.org

2) National Institute on Drug Abuse

3) NIDA-supported Research

4) Forum on Ecstasy

5) Rave Safe

6) Cannabis News

Comments made prior to 2007

After reading the article Ecstasy: Neurotoxicity and How It Can Be Reduced by Molly Flannagan I have one question. Is it suggested that a person using ecstasy take a pre-load as well as a post-load or is it suggesting to take supplements either before or after and not both times? If you did take supplements before AND after ecstasy use would you be overloading your system with vitamins? Would this be dangerous? ... Melody, 24 May 2006

"Ecstasy: Neurotoxicity and How It Can Be Reduced | Serendip's Exchange." 2 Sep. 2008 .


Reblog this post [with Zemanta]

Alcohol, tobacco more harmful than cannabis, LSD, ecstasy: study

Alcohol, tobacco more harmful than cannabis, LSD, ecstasy: study
Mar 23 11:13 AM US/Eastern
Alcohol is nearly as harmful as heroin and tobacco is more dangerous than cannabis, LSD or ecstasy, according to a new classification table of drugs published in a medical journal Friday.

The table, published in The Lancet, was drawn up by a group of leading British scientists and ranked heroin, cocaine, barbiturates and street methadone as the most harmful drugs, closely followed by alcohol in fifth place.

Tobacco was assessed to be the ninth most dangerous drug behind ketamine -- commonly used as a horse tranquilizer -- benzodiazepines, which are prescription tranquillisers, and amphetamines.

Cannabis was said to be the 11th most harmful. LSD was ranked 14th and so-called "clubbers' drug" ecstasy in 18th, or third last, place.

The classifications were based on individual drugs' so-called "harm scores" -- the physical damage to the user; how likely the drug was to induce dependency; and the effect of its use on families, communities and society.

Each of the three categories was split into nine categories of risk and independent experts including psychiatrists, chemists and forensic scientists ranked each category on a scale from 0 ("no risk") to 3 ("extreme risk").

Heroin scored 2.7 on the harm scale with alcohol just under 2. Tobacco scored 1.7 and ecstasy scored just over 1.1.

One of the scientists, Professor Colin Blakemore, the chief executive of the government-funded public health body the Medical Research Council, said their findings differed markedly from the existing drugs classification in Britain.

"Alcohol and tobacco are way up there in the league table, with alcohol being not very far behind demonised terrors of the street like heroin," he said.

His colleague, Professor David Nutt, from the University of Bristol, western England, said isolated cases of unpleasant and unpredictable responses to drugs were allowed to dictate policy.

"A more scientific view is that these risks have to be assessed against their effect on the whole population," he added.

Possessing Class A drugs like heroin, cocaine and crack, ecstasy and LSD currently carries a maximum seven-year prison sentence; cannabis is a Class C drug, while alcohol and tobacco are unclassified.

Blakemore said he hoped policy makers would "take note" that their table differed substantially from the official classification, which a separate British study published on March 8 also criticised as inadequate.

The RSA Commission on Illegal Drugs, Communities and Public Policy said Britain's drug laws should be replaced by a system recognising the harm to health of substances like alcohol and tobacco rather than crime prevention.


Copyright AFP 2005, AFP stories and photos shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium

http://www.breitbart.com/article.php?id=070323151313.ezfzedyy&show_article=1&catnum=0
Reblog this post [with Zemanta]

Ecstasy approved for medical study

CNN.com
Powered by

Ecstasy approved for medical study

WASHINGTON (CNN) --A South Carolina psychiatrist said Wednesday he will immediately start recruiting patients after winning approval to conduct the first study testing MDMA -- better known as ecstasy -- as a therapeutic tool.

Dr. Michael Mithoefer plans to conduct psychotherapy sessions with 20 women who suffer from post-traumatic stress disorder due to sexual assaults or other violence, and who haven't been helped by other treatment. Twelve of the women will receive MDMA prior to the sessions while eight will be given a placebo.

The Food and Drug Administration approved Mithoefer's protocol in 2001, but it took another two years to find an institutional review board willing to sanction the study, which is a required step when dealing with human research subjects.

Mithoefer's research required approval from the Drug Enforcement Administration because MDMA is a Schedule I drug. It's grouped with drugs like heroin, cocaine and LSD, all considered to have no medical use.

Bill Grant, a spokesman for the DEA, said the final approval came Tuesday night.

Mithoefer says he works with post-traumatic stress disorder patients all the time and he's excited about the possibility of finding a better treatment for the hundreds of thousands of Americans who suffer from the sometimes debilitating disorder.

"We owe it to them," he said. "It would be irresponsible for the medical community not to investigate something like this."

At the same time, he warns that using MDMA in an uncontrolled setting can be very dangerous.

"It's really important for people to realize the fact that we have permission to do this study and we can do it safely in this setting," he said.

Also, the fact that he's received permission for the study, he said, "does not mean that you can use ecstasy safely and anywhere."

MDMA was first invented in 1912 but largely ignored until young people made it a recreational drug starting in the late 1970s. Psychiatrists quickly became aware of its unusual properties, and several dozen experimented by giving MDMA to patients -- including people suffering post-traumatic stress disorder -- and others with intense anxiety after receiving diagnoses of terminal cancer.

One of those patients from the early 1980s is an artist now living in the western United States, who spoke with CNN. She did not want her name used.

After being raped and beaten at age 17, the woman suffered severe panic attacks for eight years, leading to three hospitalizations before being treated with MDMA. Before those sessions, she said her trauma was misdiagnosed as schizophrenia, severe depression and bipolar disorder.

"MDMA allowed me, for the first time, to sit with the details of the event, and separate them from what was happening in the present," she told CNN. "I was able to relax my body. I was able to say, 'this is not happening to you right now.' "

Suicidal at the time, she said the treatment may have saved her life.

"There might have been another way, but the way that I see it is that I probably would have died," she said.

"When someone is traumatized, walls form around trauma -- like a scar -- and it's hard to get someone to open up and talk about it," explains Dr. Julie Holland of New York University, author of "Ecstasy: A Complete Guide."

"What's unique about MDMA is that it's actually stimulating but decreases anxiety," Holland told CNN. "It could help people feel calm and comfortable enough to explore painful things that are hard to talk about."

"A good analogy is that it would give psychiatry something akin to anesthesia during therapy," she said. "And unlike anesthesia, your memory is completely intact, but even enhanced. You remember the trauma very clearly, but are comfortable enough to talk about it."

"Because it anesthetizes the patient to some extent," Holland said, "you can get to that malignant core in one or two sessions instead of three or four years."

But Dr. Scott Lillienfeld, a psychiatrist at Emory University who has studied post-traumatic stress disorder, said that hypothesis is "at the least, muddled."

Lillienfeld said effective treatment actually requires the patient to face their trauma head-on. "If you're calm, you're not getting at the root of the problem," said Lillienfeld.

He also said Mithoefer's study has methodological problems.

"There's no real placebo," he said. "Everyone will know who's on the drugs. What I wonder is, instead of a placebo, why aren't they giving a drug that mimics the physical effects?"

Mithoefer said all participants will have to undergo psychiatric screening and a physical exam to ensure they don't have any physical risk factors. Ecstasy, a strong stimulant, is thought to be particularly dangerous to people with high blood pressure. It also has been known to cause dangerous overheating in people who take it and then exercise or dance for a long period of time.

Patients in this clinical trial will be given the drug only one or two times. They will be under a doctor's supervision for the entire time they are under the drug's influence.

Mithoefer said he hopes to begin the actual therapy sessions next month.

CNN producers Caleb Hellerman and Miriam Falco contributed to this report.


Find this article at:
http://www.cnn.com/2004/HEALTH/02/25/ecstasy.study/index.html
Check the box to include the list of links referenced in the article.
� 2008 Cable News Network

Reblog this post [with Zemanta]

EcstasyData.org: Ecstasy Lab Testing & Analysis Results - Ecstasy Pill Reports

EcstasyData.org: Ecstasy Lab Testing & Analysis Results - Ecstasy Pill Reports

Ecstasy Lab Results
Most Recent Data

Prescription Ecstasy and Other Pipe Dreams - 10 Zen Monkeys

A fractal pattern similar to the spiral patter...Image via Wikipedia Prescription Ecstasy and Other Pipe Dreams - 10 Zen Monkeys: "Are psychedelic drugs medicinal? Can you picture yourself walking into the neighborhood pharmacy with prescriptions for ecstasy (MDMA) and psilocybin?"

Reblog this post [with Zemanta]